BioSpace News Archive

The Honourable Ginette Petitpas Taylor, federal Minister of Health, will deliver opening remarks at the National Conference on Post-Traumatic Stress Disorder.

This year’s conference will discuss the multidisciplinary care of gastrointestinal cancers with emerging therapies and evolving standards of care, now in Washington DC

Addus HomeCare Corporation announced the hiring of Sean P. Gaffney as the Company’s Executive Vice President, Chief Legal Officer, effective April 29, 2019.

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Bio-Rad’s IH-500, an automated random access system for blood typing and screening

F2G Ltd, the European biotech company developing novel therapies for life-threatening fungal infections, today announces the appointment of Dr Patrick Vink as Chairman of the Board of Directors with immediate effect.

SafeHeal, a leading innovator in the field of digestive surgery, announces today that its unique Colovac bypass sheath has received the CE-mark.

Pulmatrix, Inc. (“Pulmatrix,” the “Company,” “we,” “our” or “us”) (NASDAQ: PULM) today announced the closing of its previously announced underwritten public offering of an aggregate of 1,719,554 common units and 8,947,112 pre-funded units at a price to the public of $1.35 per common unit and $1.34 per pre-funded unit,

Krios G3i helps scientists stay on the leading edge of discovery

Griffin-American Healthcare REIT IV, Inc. announced that its board of directors has approved an estimated per share net asset value of its Class T and Class I common stock of $9.54 as of Dec. 31, 2018.

Uni-Bio Science Group Limited is pleased to announce the appointment of Mr. Zhao Zhi Gang as the CEO, Mr. Ma Qing Shan as independent non-executive director and Mr. Tony Yau as non-executive director of the Group, effective on 8 April 2019.